HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phillip L Pearl Selected Research

pyridoxine 5-phosphate

1/2013Partial Pyridoxine Responsiveness in PNPO Deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Phillip L Pearl Research Topics

Disease

34succinic semialdehyde dehydrogenase deficiency
02/2022 - 01/2003
28Epilepsy (Aura)
04/2022 - 09/2005
15Seizures (Absence Seizure)
01/2022 - 01/2003
7Status Epilepticus (Complex Partial Status Epilepticus)
01/2022 - 02/2006
7Brain Diseases (Brain Disorder)
11/2021 - 01/2016
7Gamma aminobutyric acid transaminase deficiency
01/2019 - 03/2004
5Pyridoxine-dependent epilepsy
01/2021 - 03/2004
4Ataxia (Dyssynergia)
02/2022 - 12/2005
4Infantile Spasms (West Syndrome)
01/2021 - 02/2009
4Aromatic amino acid decarboxylase deficiency
01/2017 - 03/2004
3Inborn Genetic Diseases (Disease, Hereditary)
02/2022 - 09/2006
3Drug Resistant Epilepsy
11/2021 - 01/2020
3autosomal recessive Segawa syndrome
05/2007 - 03/2004
3Nonketotic Hyperglycinemia
05/2007 - 12/2005
2Intellectual Disability (Idiocy)
02/2022 - 12/2005
2Muscle Hypotonia (Hypotonia)
02/2022 - 04/2010
2Partial Epilepsies (Epilepsy, Partial)
11/2021 - 01/2018
2Nervous System Diseases (Neurological Disorders)
01/2021 - 01/2016
2Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
01/2013 - 11/2006
2Traumatic Brain Injuries (Traumatic Brain Injury)
10/2012 - 08/2012
2Cleft Lip (Harelip)
05/2007 - 09/2006
2Homocarnosinosis
09/2006 - 04/2004
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
05/2005 - 11/2003
1Confusion (Bewilderment)
11/2021
1Sudden Unexpected Death in Epilepsy
11/2021
1Parkinson Disease (Parkinson's Disease)
01/2021
1Brain Injuries (Brain Injury)
01/2020
1Disorders of Excessive Somnolence (Hypersomnia)
01/2019
1Movement Disorders (Movement Disorder)
01/2019
1Edema (Dropsy)
01/2018
1Anemia
11/2017
1Failure to Thrive
11/2017
1Channelopathies
03/2016
1Inborn Urea Cycle Disorders
01/2016
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2016
1Mitochondrial Diseases (Mitochondrial Disease)
01/2016
1Molybdenum cofactor deficiency
01/2016
1Lennox Gastaut Syndrome
09/2014
1MELAS Syndrome (Syndrome, MELAS)
09/2014
1Lactic Acidosis
09/2014

Drug/Important Bio-Agent (IBA)

34gamma-Aminobutyric Acid (GABA)IBA
02/2022 - 01/2003
19Succinate-Semialdehyde Dehydrogenase (Succinic Semialdehyde Dehydrogenase)IBA
11/2021 - 01/2003
14Biomarkers (Surrogate Marker)IBA
04/2022 - 07/2015
11Neurotransmitter Agents (Neurotransmitter)IBA
02/2022 - 03/2002
9Aminobutyrates (Aminobutyric Acid)IBA
02/2022 - 12/2010
8Pyridoxine (Pyridoxin)FDA LinkGeneric
01/2022 - 12/2005
6AcidsIBA
11/2021 - 01/2003
4Dopamine (Intropin)FDA LinkGeneric
01/2021 - 10/2003
4Oxidoreductases (Dehydrogenase)IBA
01/2021 - 05/2007
4Serotonin (5 Hydroxytryptamine)IBA
01/2017 - 10/2003
4Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2015 - 12/2005
3EnzymesIBA
11/2021 - 01/2003
3VigabatrinFDA Link
01/2021 - 02/2009
3Aromatic-L-Amino-Acid DecarboxylasesIBA
01/2021 - 11/2006
3Butyric Acid (Butanoic Acid)IBA
01/2019 - 05/2007
34-hydroxybutyric acidIBA
01/2019 - 05/2007
3Anticonvulsants (Antiepileptic Drugs)IBA
11/2016 - 09/2006
3Levetiracetam (Keppra)FDA LinkGeneric
09/2013 - 08/2012
2VitaminsIBA
01/2022 - 01/2016
2Pharmaceutical PreparationsIBA
01/2022 - 01/2016
2GABA-B Receptor AntagonistsIBA
11/2021 - 10/2011
2Proteins (Proteins, Gene)FDA Link
11/2016 - 03/2003
2TaurineFDA Link
01/2016 - 03/2014
2Leucovorin (Folinic Acid)FDA Link
01/2016 - 01/2013
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2016 - 11/2006
2Levodopa (L Dopa)FDA LinkGeneric
01/2014 - 11/2006
2GABA-B ReceptorsIBA
07/2012 - 10/2011
2Methylphenidate (Ritalin)FDA LinkGeneric
05/2005 - 11/2003
1(3-aminopropyl)(n-butyl)phosphinic acidIBA
11/2021
1Lysine (L-Lysine)FDA Link
01/2021
1Losartan (Cozaar)FDA LinkGeneric
01/2018
1Adenosine (Adenocard)FDA LinkGeneric
01/2018
1AlbuminsIBA
01/2018
1AntibodiesIBA
01/2018
1IsofluraneFDA LinkGeneric
01/2018
1HMGB1 Protein (HMG1)IBA
01/2018
1Alkaline PhosphataseIBA
11/2017
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2017
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2017
1ezogabine (retigabine)IBA
10/2016
1Phenobarbital (Luminal)FDA Link
03/2016
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1Anesthetics (Anesthetic Agents)IBA
01/2016
1Sodium Channels (Sodium Channel)IBA
01/2016
1Thiamine (Aneurin)FDA Link
01/2016
1Serine (L-Serine)FDA Link
01/2016
1Biotin (Vitamin H)FDA Link
01/2016
1CreatineIBA
01/2016
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2016
1NeopterinIBA
10/2015
1Mitochondrial DNA (mtDNA)IBA
09/2014

Therapy/Procedure

12Therapeutics
01/2022 - 05/2005
3Transcranial Magnetic Stimulation
11/2021 - 07/2012
1Drug Therapy (Chemotherapy)
01/2022
1Enzyme Replacement Therapy
11/2021
1Electrodes (Electrode)
11/2021
1Extracorporeal Membrane Oxygenation
01/2020
1Topical Administration
01/2018
1Length of Stay
01/2018
1Ketogenic Diet
11/2016